Background {#Sec1}
==========

Of multiple trauma patients admitted to hospitals, 44.8% suffer from an associated thoracic injury. Thoracic trauma is the second most common injury in severely injured patients in Germany \[[@CR1]\]. Extent of thoracic injury is subject to considerable individual variation and is characterized by impairment of lung function, pleural effusion, inadequate blood oxygenation, increased release of inflammatory cytokines, and increased inflammatory cell recruitment \[[@CR2]--[@CR4]\]. In addition to injury of the osseous thorax, thoracic organs may also be affected. Thoracic trauma has been associated with longer durations of mechanical ventilation (MV) and respiratory complications such as pneumonia or acute respiratory distress syndrome (ARDS). These complications correlate to mortality rates that can be as high as 24% \[[@CR5]--[@CR7]\]. The incidence of ventilator-associated pneumonia (VAP), a frequent nosocomial infection, was shown to be highest in trauma patients, and represented a predisposing factor for the development of trauma-associated ARDS and multiple organ failure (MOF) \[[@CR8]--[@CR10]\]. The early identification of high-risk patients as well as influenceable factors that predispose patients toward developing pneumonia is of significant importance for post-traumatic pneumonia risk reduction. The heterogeneity of trauma patients (e.g. injury severity and distribution, age, pre-existing disease), however, poses a considerable challenge to the identification of discrete risk factors.

Comprehensive meta-analyses on the incidence, clinical course, and outcomes in specific subgroups of intensive care unit (ICU) patients with pneumonia are rare; most reports base their analyses on heterogeneous patient groups or include just a small number \[[@CR11]--[@CR13]\] of cases. Published data on pneumonia incidence in trauma patients offers statistics anywhere from 8% to more than 50% \[[@CR14]--[@CR23]\]. Few studies focus on severely injured patients with significant thoracic trauma, despite the fact that chest injuries have been intensively reviewed as predisposing factors for pulmonary infection \[[@CR24]--[@CR28]\]. Data on the incidence, independent risk factors, and outcomes of respiratory complications (e.g. pneumonia) in a large cohort of these patients is of urgent importance to define benchmarks by which clinical data can be compared, apply to collective quality management, and set reference data on the efficiency of new therapies such as prophylactic positive end-expiratory pressure (PEEP) ventilation, prone positioning, kinetic therapy, and the use of antibiotics.

In the present study, we collected epidemiological, clinical, and outcome data from a large group of severely injured ICU patients with thoracic trauma to determine the rate of respiratory complications therein in a retrospective, multi-centre approach. We focused on pneumonia rates, risk factors, and underlying pathogens in bronchoalveolar lavage fluid (BALF).

Methods {#Sec2}
=======

This study was produced by the Trauma Committee of the German Interdisciplinary Association for Intensive and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin, DIVI). In December 2015, the committee embarked on a retrospective, observational study of the quality of care in patients with thoracic trauma that underwent MV from the years 2010 to 2014. Six German hospitals (Aachen, Cologne, Frankfurt, Freiburg, Kiel and Marburg) contributed patient data for analysis. All participating hospitals were Level I trauma centres.

This study follows the guidelines of the revised UN declaration of Helsinki in 1975 and its latest amendment in 2013 (64th general meeting). The following approvals were provided by each institution's ethical committee: Aachen: EK 346/15, Cologne 18/2016, Frankfurt: 220/16, Kiel: B 248/16, Freiburg: 275/16, Marburg: No ethics committee vote necessary for retrospective chart analysis. Due to the study's retrospective nature, informed consent from the study participants was not required, in accordance with the ethical approvals from the institutional committees.

All six hospitals participate in the nationwide TraumaRegister DGU® (TR-DGU) of the German Trauma Society (Deutsche Gesellschaft für Unfallchirurgie, DGU). The TR-DGU was founded in 1993 with the aim of creating a multi-centre database for pseudonymized and standardized documentation of severely injured patients for the purposes of research. Participating hospitals are primarily located in Germany (90%), but a rising number of hospitals from other countries have begun to contribute data as well, to include Austria, Belgium, China, Finland, Luxembourg, Slovenia, Switzerland, The Netherlands, and the United Arab Emirates. Currently, approximately 30,000 cases from more than 900 hospitals are entered into the database per year. Participation in the TR-DGU is voluntary; however, hospitals associated with the TraumaNetzwerk DGU® are obligated to enter at least one basic dataset for quality assurance purposes.

Data were collected prospectively over four consecutive time phases from site of injury until discharge from hospital, as follows: A) pre-hospital phase, B) emergency room and initial surgery, C) intensive care unit, and D) discharge. Documentation included detailed information on demographics, injury pattern, comorbidities, pre- and in-hospital management, course of care while in the intensive care unit, relevant laboratory findings (including data on transfusion), and clinical outcome for each individual. Inclusion criteria were: admission to hospital via emergency room with subsequent ICU/ICM care, or entrance to the hospital with vital signs and death prior to admission to the ICU.

Infrastructure for documentation and data management was provided by the Academy for Trauma Surgery (AUC -- Akademie der Unfallchirurgie GmbH), a company affiliated with the German Trauma Society. Scientific leadership draws from the Committee on Emergency Medicine, Intensive Care, and Trauma Management (NIS Committee) of the German Trauma Society. Participating hospitals submitted pseudonymized data into a central database via web-based application. Scientific data analysis was approved according to a peer review procedure established by the NIS Committee.

While the TR-DGU has been used as database for numerous analyses and publications on severely injured patients \[[@CR29]\], analyses are restricted to what has been uploaded by the institution, and documentation with regards to respiratory clinical course and complications is limited. For the purposes of this study, each individual hospital retrieved its own data from the database and added relevant information from clinical documentation systems. The study group chose to retroactively include all patients from the six study sites that fulfilled the following criteria:Age ≥ 18 yearsPrimary admissionsAbbreviated Injury Scale (AIS~thorax~) ≥ 3Admitted between the years of 2010 and 2014ICU treatment ≥1 day

For these patients, data was retrieved from the TR-DGU by the hospitals involved in this study following approval from the participating hospitals and the TR-DGU. Data were complemented by a review of the patients' records from each hospital. Additional data were pseudonymized and added to the TR-DGU data as follows:Bronchoalveolar lavage (BAL) yes/noBAL positive yes/no, if yes, pathogen detailsAspiration yes/noTracheotomy yes/noMV in hoursRe-intubation for respiratory needs yes/noPneumonia yes/no (CPIS \> 6 or as described below), if yes: VAP/hospital acquired pneumonia (HAP)/other, and early vs. late onsetCPIS (maximum)Discharge on MV yes/noPulmonary comorbidities (predefined list), if yes: nWorst Horowitz Index valueHighest PEEPIn case of discharge on MV, worst Horovitz Index and highest PEEP as determined from the first 14 days of MV

Overall injury severity was calculated by the Injury Severity Score (ISS) as described by Baker et al. \[[@CR30]\]. The Clinical Pulmonary Infection Score (CPIS) was used to assess the occurrence of pneumonia in ventilated patients \[[@CR31]\]:Body temperature (°C): 36.5--38.4 = 0 point; 38.5--38.9 = 1 point; \> 39.0 or ≤ 2 pointsWhite blood cell count (microscopy): 4000-11,000/mm^3^ = 0 point; \< 4000/mm^3^ or \> 11,000/mm^3^ = 1 point; either \< 4000 or \> 11,000/mm^3^ plus band forms ≥50% = 2 pointsTracheal Secretions: None or scant = 0 point; tracheal secretion with less purulence = 1 point; abundant purulent secretion = 2 points.PaO~2~/FiO~2~: \> 240, ARDS or pulmonary contusion = 0 point; ≤240 and no ARDS = 2 pointsChest Radiograph: No infiltrate = 0 point; diffuse (or patchy) infiltrate = 1 point; localized infiltrate = 1 pointProgession in pulmonary infiltration: no = 0 point; yes (after the exclusion of HF and ARDS) = 2 pointsPathogenic bacteria in tracheal aspirate culture: no or few pathogenic bacteria = 0 point; moderate or high levels of pathogenic bacteria = 1 point; pathogenic bacteria to be seen in Gram staining = add 1 point

A total of \> 6 pts. was accepted as pneumonia.

In non-ventilated patients, pneumonia was defined as the presence of new progressive infiltrate accompanied by at least two of the following symptoms:Purulent respiratory secretionsBody temperature ≥ 38 °C or ≤ 35 °CLeucocytosis (white blood cell count of ≥10,000/mm^3^) or leucopoenia (white blood cell count of ≤4500/mm^3^, or more than 15% immature neutrophils)

Standard for numeric results of BAL was utilized following recommendations of the German Society of Hygiene and Microbiology \[[@CR32]\].

Continuous variables were compared using Student's *t*-test and categorical variables analysed using the Chi-square test. Results are presented as mean plus or minus standard deviation (SD) with a confidence interval (CI) of 95%. Analyses were performed with SPSS (Version 25.0, SPSS, Inc.) for Windows. A two-tailed *p*-value ≤0.05 was considered significant. The interpretation of results, however, should focus on clinically relevant differences rather than on significant *p*-values.

Results {#Sec3}
=======

In total, 1162 patients from the six Level I trauma centres met the inclusion criteria during the 5 year observation period. Of these patients, 1119 (96.3%) presented with complete pneumonia occurrence datasets; these datasets were entered for analysis. Basic epidemiological and outcome data were analysed for the whole cohort. The majority of patients were male (76.2%) and suffered from thoracic trauma; mean age was 48.4 years (mean: 48.39, range: 18 to 94, SD ± 18.65). Basic demographic data are detailed in Table [1](#Tab1){ref-type="table"}.Table 1Basic data of study collective, means given with SD and 95% CI, ^a^complete data on pneumonia (96.3%), ^b^median with 25th 75th percentileBasic datan1162 (1119^a^)ISS (pts.)27.5 ± 12.6RISC II mortality prognosis (%)11.6Hospital mortality (%)8.9 (7.2--10.5)SMR0.764 (0.623--0.905)AIS~thorax~ (pts.)3.6 ± 0.8Male (%)76.2 (73.8--78.7)Age (yrs.)48.4 ± 18.7Penetrating trauma (%)3.6 (2.5--4.6)ICU (days)10.5 ± 12.7GOS^b^4 (4--5)

About one quarter of patients (308/1119, 27.5% \[95% Cl, 24.9--30.1%\]) fulfilled the criteria for a pneumonia diagnosis. Classification of the type of pneumonia was possible in 290 patients. In 24.5% of these cases, HAP (while not ventilated) was diagnosed, 42.1% were early-onset VAP (1--4 days of MV), and 33.4% were late-onset VAP (5 days or more). Table [2](#Tab2){ref-type="table"} compares epidemiological, clinical, and outcome data from patients with pneumonia versus patients without pneumonia. Patients with pneumonia were significantly more severely injured (mean ISS: 32.6 ± 12.8 vs. 25.4 ± 11.8, *p* \<  0.001) and older (mean age in years: 51.3 ± 18.9 vs. 47.5 ± 8.5, *p* = 0.002). Length of ICU stay (mean in days: 21.8 ± 15.4 vs. 6.3 ± 8.1, *p* \<  0.001) and duration of MV (mean in hours: 368.9 ± 303.1 vs. 114.9 ± 161.4, *p* \<  0.001) were significantly longer in the pneumonia group. Incidences of reintubation and tracheotomy were significantly higher in patients with pneumonia. In contrast, hospital mortality was only slightly higher in the pneumonia group (mean: 10.1%, 6.7 to 13.4 vs. 7.9%, 6.0 to 9.7, *p* = 0.3).Table 2Comparison of patients with and without pneumonia, means given with SD and 95% CI, ^a^median with 25th -- 75th percentileNo pneumoniaPneumonia*p* valueN811 (72.5%)308 (27.5%)--ISS (pts.)25.4 ± 11.832.6 ± 12.8\<  0.001RISC II mortality prognosis (%)8.819.5%\<  0.001Hospital mortality (%)7.9% (6.0--9.7)10.1% (6.7--13.4)0.30AIS~head/neck~ (pts.)1.4 ± 1.72.3 ± 1.9\<  0.001AIS~thorax~ (pts.)3.5 ± 0.73.7 ± 0.8\<  0.001AIS~abdomen~ (pts.)0.9 ± 1.41.0 ± 1.40.88AIS~extremities~ (pts.)1.6 ± 1.42.0 ± 1.4\<  0.001Male (%)74.4 (71.3--77.4)80.8 (76.4--85.2)0.028Age (yrs.)47.5 ± 18.551.3 ± 18.90.002Penetrating trauma (%)4.3 (2.9--5.6)1.3 (0.0--2.6)0.027LOS (days)16.3 ± 15.129.1 ± 19.4\<  0.001ICU (days)6.3 ± 8.121.8 ± 15.4\<  0.001Time on ventilation (h, all)58.0 ± 128.2346.0 ± 306.7\<  0.001Time on ventilation (h, ventilated patients)114.9 ± 161.4368.9 ± 303.1\<  0.001GOS^a^5 (4--5)4 (3--5)\<  0.001BAL (%)4.9 (3.4--6.4)79.5 (75.0--84.1)\<  0.001Aspiration (%)3.3 (2.1--4.6)21.1 (16.5--25.7)\<  0.001Tracheotomy (%)4.6 (3.1--6.0)44.8 (39.3--50.4)\<  0.001Reintubation (%)2.5 (1.4--3.5)17.9 (13.6--22.1)\<  0.001Discharge on ventilation (%)2.2 (1.2--3.2)17.3 (13.0--21.5)\<  0.001Worst Horovitz Index282.9 ± 135.7137.8 ± 83.4\<  0.001ECMO (%)0.4 (0.0--0.8, *n* = 3)0.0 (*n* = 0)1.0

In the majority (79.5%) of patients with pneumonia (73.1% of VAP patients), a BAL for microbiological culture was performed. In 39 of these cases, microbiological cultures were negative. In the remaining 206 cases (84.1, 95% Cl 79.5--88.7%), cultures were positive for at least one pathogen (Table [3](#Tab3){ref-type="table"}), the most common single species of which was *Staphylococcus aureus* (18.1%), followed by various gram-negative bacteria. In 10.8% of these cases, *Candida* species were identified.Table 3Isolated Pathogens in Bronchoalveolar LavagesNamen (%)TypeEnterobacter species121 (36.4)Gram-negative *Escherichia coli*46 (13.9) *Klebsiella pneumonia*38 (11.5) Serratia species14 (4.2)*Staphylococcus aureus*60 (18.1)Gram-positiveCandida species36 (10.8)Fungus*Haemophilus influenza*29 (8.7)Gram-negativePseudomonas species22 (6.6)Gram-negativeIsolated pathogens in qualitative bronchoalveolar lavages from patients developing pneumonia during intensive care treatment; pathogens wit *n* \< 10: *Streptococcus, Enterococcus, Neisseria, Aspergillus, Anaerobic, Citrobacter, Proteus, Herpes, Acinetobacter, Morganella, Pneumococcus, Havnia*

Duration of MV was significantly correlated to pneumonia occurrence (Fig. [1](#Fig1){ref-type="fig"}). The MV duration cut-off point that most accurately discriminated between patients who would and those who would not develop pneumonia during their hospital stay was 102 h.Fig. 1Rates of pneumonia (%) versus time on mechanical ventilation (h), 95% CI are shown, p overall \< 0.001; \* = significant increase to left datapoint

Overall injury severity as indicated by the ISS also significantly correlated to pneumonia incidence. Significantly higher rates of pneumonia (*n* = 178) (95% CI 31.1--51.7%, *p* \<  0.001, r = 0.267) were observed in patients with an ISS of at least 25 (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Rates of pneumonia (%) versus Injury Severity Score (pts.) in trauma patients with chest injury (AISThorax 3), 95% CI are shown, p overall \< 0.001; \* = significant increase to left datapoint

Multivariate logistic regression analysis with pneumonia as the dichotomous dependent variable revealed that certain independent factors were significantly associated with development of pneumonia; these were sex, age, hours of MV, and aspiration event. Severity of thoracic trauma (AIS~thorax~), ISS, and presence of pulmonary comorbidities did not demonstrate a significant association with pneumonia occurrence (Table [4](#Tab4){ref-type="table"}).Table 4Odds ratios for parameters that showed independent association with the occurrence of pneumonia in multivariate analysis; parameters without significant association were: ISS, AIS~thorax~ = 4, AIS~thorax~ = 5, blunt/penetrating trauma mechanism, pulmonary comorbiditiesVariableOdds ratio95% CI*p* valueAspiration5.9743.420--10.436\<  0.001Age (per year)1.0121.003--1.0210.012Mechanical ventilation (per h)1.0051.005--1.006\<  0.001Female sex0.5490.359--0.842\<  0.001

Discussion {#Sec4}
==========

This study analysed observational data on severely injured patients with thoracic trauma collected from six German Level I trauma centres. Only a handful of previous studies, each with small samples, have investigated the incidence of pneumonia in severely injured patients. With this study, we aimed to explore the incidence of pneumonia in the largest cohort of severely injured patients with thoracic trauma investigated thus far. Our main findings can be summarized as follows:Sex, age, duration of MV, and aspiration were all independent predictors for occurrence of pneumoniaISS, ICU stay, and reintubation and tracheotomy were each significantly associated with pneumonia.Pneumonia in and of itself did not result in significantly different mortality rates.The cut-off point past which the duration of MV was most likely to predict pneumonia was 102 h.

Our study cohort yielded a similar distribution of basic epidemiological data, (mean age of about 48, approximately three-quarters male at 76%), as that found in the nationwide TR-DGU (mean age 51.2; 69% male) \[[@CR1]\]. However, mean ISS was higher in our study as compared to the nationwide TR-DGU (27.5 vs. 18.4). This difference is likely due to the AIS~thorax~ ≥ 3 required for inclusion in our study, as severe thoracic trauma is known to be significantly associated with a higher ISS \[[@CR33]\]. We consider our specific sample to be an important representative cohort for providing reference data for the occurrence of pneumonia in severely injured patients with thoracic trauma.

Incidence of pneumonia {#Sec5}
----------------------

In our study, the overall incidence of pneumonia was 27.5%. In order to calculate the rate of VAP, we excluded hospital-acquired pneumonia (developed during non-ventilation phases). This resulted in a VAP rate of 20.8%, which is in alignment with reports indicating that VAPs represent between 60 and 80% of nosocomial pneumonias \[[@CR34], [@CR35]\].

Incidences of pneumonia in severely injured patients range from 8% to more than 50% in the literature \[[@CR14]--[@CR23]\]. Reports employing the specific inclusion criteria of the present study (severely injured patients with significant thoracic trauma) resulted in pneumonia rates between 13.2 and 45% \[[@CR16], [@CR36]\]. Many factors could possibly explain this discrepancy; First, previous studies focusing on severely injured patients with thoracic trauma only included a small number of patients (*n* = 79 and *n* = 223), necessarily limiting the predictive power of the results. Second, a lack of standard diagnostic criteria and consensus surrounding the definition of pneumonia permeates medical practice; this can result in significant variations in reported rates, making it challenging to identify of high risk patients. Third, incidence reporting differed among different institutions (e.g. trauma service vs. infection control) as well as whether a clinical strategy or a bacteriologic strategy was employed for VAP diagnosis \[[@CR19], [@CR20], [@CR23]\]. Fourth, demographic and clinical differences within trauma populations are an important consideration. In this context, significant differences in ISS (e.g. \< 16 vs \> 35 points) can have a considerable impact on the duration of MV as well as the incidence of pneumonia itself \[[@CR16], [@CR17]\]. Lastly, therapeutic modalities can also affect the development and course of the pneumonia. In a single centre trial, effects of continuous lateral rotational therapy on patients undergoing post-traumatic courses of care were investigated \[[@CR16]\]. Authors observed a reduction in MV duration and time spent in the ICU following this therapy. By the same token, they also reported a low incidence of VAP (13.2%). As rotational treatment was not routinely provided to patients examined in this and other studies \[[@CR23]\], it could be inferred that this therapy might be associated with a lower VAP rate \[[@CR20], [@CR36]\]. This is an interesting finding that deserves future research.

We believe the high number of patients and combined clinical-diagnostic and bacteriologic parameters for diagnosis of pneumonia and VAP in this investigation has yielded important data points with regards to the incidence thereof in severely injured patients with thoracic trauma.

Risk factors for occurrence of pneumonia {#Sec6}
----------------------------------------

In our study, patients with pneumonia had a higher ISS, were older, and were more likely to be male. Pneumonia correlated to a two-fold decrease in Horowitz Index, a three-fold increase in time under MV, and a prolongation of ICU treatment and total length of stay (LOS). Patients with pulmonary infections were also more likely to have suffered an aspiration event and receive tracheotomy or reintubation. These aspects might contribute to the poorer clinical outcomes, measured by Glasgow Outcome Scale (GOS), observed in pneumonia patients in this study's cohort. Our epidemiologic data was in agreement with previous studies that included severely injured patients (regardless of thoracic trauma) that found higher age, higher ISS, lower Glasgow Coma Scale (GCS), and more severe head and extremity trauma (based on AIS) to be predispositions for pneumonia \[[@CR17], [@CR18], [@CR21]\]. In addition, a sex-related risk for post-traumatic infections in male patients has been well-established; beneficial effects of female hormones on the immune system have been suggested as a potential cause for this disparity between the sexes \[[@CR37], [@CR38]\]. With regards to clinical course, increased durations of MV as well as ICU stay and LOS in cases of post-traumatic pneumonia have also been reported \[[@CR21], [@CR22]\].

Among the factors discussed above, we identified aspiration, sex, age, and duration of MV as independent risk factors for the development of pneumonia. In summary, we found two influenceable risk factors for the occurrence of pneumonia: aspiration and duration of mechanical ventilation. The highest risk was observed for aspiration events (OR 5.97), which underscores data from other studies indicating aspiration as a common risk factor for the development of pneumonia \[[@CR27], [@CR39]\]. The importance of age, sex, and duration of MV as independent risk factors for pneumonia have been emphasised for trauma patients in many reports, regardless of the presence of thoracic trauma \[[@CR26], [@CR40]--[@CR42]\].

In our multivariate analysis, we did not observe the association between ISS and pneumonia reported by a majority of previous studies \[[@CR15], [@CR21], [@CR24], [@CR27], [@CR42], [@CR43]\]. As other studies specified severe injuries to specific body regions (AIS~head~, AIS~chest~, AIS~extremity~) as being independently associated with the development of pneumonia, we surmise that injury location rather than overall severity is of greater diagnostic importance \[[@CR21]\]. Several studies have reported preclinical intubation as an independent risk factor for the development of pneumonia \[[@CR21], [@CR27], [@CR28]\]. Due to parameters specific to the German health system, wherein first responders include physicians, almost all patients in our study were intubated at the scene of injury prior to admission to the hospital, rendering us unable to reliably report on the time point of intubation.

We found no significant effect of pneumonia on post-traumatic mortality, although Revised Injury Severity Classification Score II (RISC II) mortality prognoses were much higher for the pneumonia group. This could be because RISC II prognosis considers uncontrolled bleeding a major cause of death, as is more likely to occur in our study cohort of severely injured patients \[[@CR44]\]. Other studies have similarly found that pneumonia incidence did not influence the likelihood of post-traumatic mortality \[[@CR10], [@CR21], [@CR26], [@CR45]\]. A study by Fahr et al. (2017) did demonstrate a trend wherein pneumonia incidence was correlated to that of mortality. Fahr's team contended that an increase in the number of pneumonia cases could partially explain the higher mortality rates observed in their study \[[@CR22]\]. Sharpe et al. (2014), however, identified pneumonia as an independent risk factor for mortality only in females, whereas another study identified pneumonia as an independent predictor of mortality only in less severely injured patients (mean ISS \< 16) \[[@CR17], [@CR41]\]. Similar results were reported by Gannon et al. (2004) for patients presenting with injuries of minor and moderate severity \[[@CR40]\]. It could therefore be cautiously assumed that pneumonia exerts relevant effects on mortality only in specific subgroups of trauma patients, particularly those without severe injuries as the impact of injury on mortality in patients with a minor to moderate ISS is usually low. It follows that the effect of post-traumatic complications (e.g. pneumonia) on mortality might be substantially more relevant in these patients. It is also worth pointing out that the number of patients in each of these studies is too small to make any overarching statements about pneumonia and mortality vis-à-vis these trauma subgroups. Such findings should instead be a jumping-off point for potential future comparative studies focusing on mortality as a potential end point.

Pathogens in BAL {#Sec7}
----------------

In \> 80% of the patients in our study with pneumonia, diagnostic BAL was performed as recommended by national guidelines for nosocomial pneumonia \[[@CR46]\]. Pathogens were identified in 84.1% of all BAL procedures performed on this study's cohort. In a previous multicentre study, "EU-VAP/CAP," Koulenti et al. (2017) reported a similar detection rate \[[@CR47]\]. The most common pathogens in our study were Enterobacteriaceae (36.4%) and *Staphylococcus aureus* (18.1%), similar to results from previous studies on severely injured patients with and without severe thoracic trauma \[[@CR10], [@CR43], [@CR47], [@CR48]\]. The high rate of gram-negative organisms (e.g. Enterobacteriaceae) is almost certainly associated with the high incidence of aspiration events in the development of pneumonia. The relevance of *Staphylococcus aureus*, particularly in patients with thoracic trauma, has been emphasized by Fahr et al. (2017) who found that subjects with contusions were more likely to grow methicillin-sensitive *Staphylococcus aureus* \[[@CR36]\]. Polymicrobial infections presented in around one third of the cases (35.1%) in accordance with results from previous studies \[[@CR47], [@CR49]\].

When interpreting the pathogen spectrum, the importance of geographical origin of the study population cannot be overstated. In this context, a study from Qatar identified *Klebsiella pneumoniae* and *Hemophilus influenza* as the microorganisms most commonly associated with post-traumatic pneumonia. In our study, however, these pathogens played but a minor role \[[@CR26]\].

Strengths and limitations {#Sec8}
-------------------------

While the large cohort for this study enables certain important statements about this patient group, this study has some relevant limitations. Retrospective registry studies are restricted to initially documented data; some points of interest may not be precise enough for solid scientific analyses, e.g. the exact time points of BAL procedure, or presentation versus definitive diagnosis of pneumonia. Additionally, in consequence of a multi-centre approach, some inconsistency in data collection is inevitable. Standardised scores (e.g. CPIS) and national guidelines were used to standardize data collection to the extent possible. Moreover, approximately 3.7% of all datasets were excluded due to missing data referring the occurrence of pneumonia. Although this might have influenced our results, we expect this bias to be of minor effect. As with any study of this nature, the data only supports association, rather than causation. Furthermore, the following diagnostic limitations need to be considered: A) initial chest X-ray might not have shown infiltrates apparent in the first 72 h, B) chronic changes on chest X-ray might have been misinterpreted as acute pneumonic infiltrates, C) presence of bacteria in sputum or endotracheal is known to be sensitive, but non-specific. This might have led to overtreatment and higher false positive rates.

Despite these limitations, this study presents a large cohort evaluating influenceable risk factors for the occurrence of pneumonia in severely injured patients with relevant thoracic trauma.

Conclusions {#Sec9}
===========

This report is the first to characterise post-traumatic pneumonia and its impact on clinical course in a large cohort of severely injured patients with significant thoracic trauma. Identification of specific risk factors, details of clinical course, and most common triggering pathogens could help to better prevent, diagnose, and treat pulmonary infections in these patients. Further studies are needed to describe the incidence of pneumonia in specific subgroups of traumatized patients.
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